This is the breadcrumbs block. Breadcrumb will populate on actual page.

In Conversation with Praxis SCI Incubate Cohort Members

The Praxis SCI Incubate 2020 Cohort includes companies with transformative technologies that have demonstrated application to impact outcomes, including spinal cord injury (SCI) cure and quality of life.

Learn more about the companies, their founders and innovations through their growth stories.

AXONIS Therapeutics, Inc

Axonis Therapeutics is a Boston-based biotechnology company committed to developing groundbreaking therapies for spinal cord injury, neuropathic pain, and other incurable neurological disorders through tissue reactivation and neuron regeneration.

Read their story  

Joanna Stanicka, PhD, CEO & Co-Founder, talks about restoring movement in paralyzed patients after SCI through tissue reactivation and neuron regeneration.

Elevation Products

Elevation Products sells a selection of wheelchair accessories and assistive technology products developed at Dr. Borisoff’s applied research lab. The company is owned by Instinct Mobility Inc., the company Dr. Borisoff founded to commercialize his Elevation Wheelchair invention 15 years ago.

Read their story

Dr. Jaimie Borisoff talks about SWIVL™, an innovative technology that helps people with SCI participate in outdoor activities without compromising their indoor mobility.

Purus Innovations

Purus Innovations provides highly efficacious coating solutions to prevent the buildup of fouling components on the surface of materials used in medical and industrial applications.

Read their story

Dr. Dirk Lange, Co-Founder, Purus Innovations talks about how the company started and its innovative technology to prevent Urinary Tract Infections (UTIs).


Spiderwort is building the framework for the future of regenerative medicine through the development of innovative plant-based biomaterials that promote the repair and regeneration of living tissues, including the spinal cord.

Read their story

Dr. Charles M. Cuerrier, CEO & Co-Founder, and Dr. Stephen Hanson, MBA, Business Development Director, talk about their cellulose scaffolding innovation that promotes regeneration after SCI.

Starling Medical

Starling Medical is developing an AI-enabled, connected urinary prosthesis for individuals with neurogenic bladder dysfunction. The UrinControl System allows people to use the bathroom quickly and safely at the push of a button, replacing the hundreds of monthly intermittent catheters with just a single device.

Read their story

CEO Dr. Alex Arevalos and Director of Product Development Sylvie Kalikoff, MBE, talk about  revolutionizing neurogenic bladder management with an AI and tech-enabled platform.

Learn more about Praxis SCI Incubate Program